Health News
Date: May-15-2012
Strategies for navigating the regulatory, manufacturing, sales and marketing route to biosimilar market entry. 11 - 13 September 2012, Jumeirah Carlton Tower, London, UK Get competitive insight into global regulatory strategies, and find out how to successfully bring biosimilars to-market in developed and developing regions. With leading companies from India, Israel, Switzerland, UK, USA, Germany and more speaking at the World Biosimilars Congress, this is a great opportunity to get a complete overview of the development pathway for biosimilars in your region of interest, and find out which...
Date: May-15-2012
The advocates of proposition 19, the bill that tried to legalize cannabis in California, must be turning cartwheels at the news coming out of University of California, San Diego School of Medicine. It's especially ironic coming just a few weeks after the Federal raid and almost complete shutdown of Oaksterdam University, the privately run school in Oakland, California that teaches students how to grow and harvest the much derided herb. A clinic trial of 30 adult patients suffering from Multiple Sclerosis appears to have demonstrated its ability to reduce spasticity and pain, when compared to a...
Date: May-15-2012
Biosimilar development costs are high with some industry leaders claiming estimates of $100-150 million. Even after this substantial investment there is no guarantee of immediate return. With the FDA, America's regulatory body, struggling to agree on a suitable approval pathway for biosimilars to reach market in the U.S. and similar marketing and associated costs to innovator drugs, biosimilars have their work cut out.
Date: May-15-2012
Why Should You Attend? 3rd Annual Pharmacovigilance 2012 - "Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management" Get more from the event, with a broader scope bringing the whole communications value chain to gather. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the technology of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and technologies in the high-level conference. Key themes to be discussed at this summit:...
Date: May-15-2012
There is a great deal of unmet need in the effective treatment of numerous types of cancer, as long-term survival rates are still rather poor for a number of cancers. There is a strong need for more effective therapies that will extend survival, with potential for new immunostimulatory therapies and other biologics to stabilize cancer and prevent metastasis. There have so far only been three cancer vaccines approved by the FDA, and many others are now nearing the end of their clinical trials. Two of these were vaccines for HPV, which is responsible for 70% of cervical cancer. The most recent,...
Date: May-15-2012
Some non-oral hormonal contraceptives, such as vaginal rings, implants and skin patches carry a higher risk of venous thromboembolism - blood clots - when compared to oral contraceptive pills, researchers from the University of Copenhagen revealed in the BMJ (British Medical Journal). The authors wrote that some patients should change over to oral, hormonal contraceptives to reduce their risk of developing clots. Venous thrombosis is a collective term for DVT (deep vein thrombosis) and pulmonary embolism. The researchers explained that most studies have focused on the clot risk for females on...
Date: May-15-2012
A study presented by Dr. Renaud Mazeron at the World Congress of Brachytherapy reveals that many cases of hysterectomy, as well as recurrence and spreading of cancer of the cervix can be controlled effectively by delivering radiotherapy directly to the cancer with 3-D imaging techniques. After reviewing using 3-D image guided adaptive brachytherapy (IGABT) in 163 patients who received a course of concomitant chemoradiation, i.e. chemotherapy combined with radiotherapy at the Institut Gustave Roussy in Villejuif, France between 2004 to 2009, Dr. Mazeron and his team observed far superior...
Date: May-15-2012
Dr. Richard Weiler, a medical sport and exercise specialist reports in the British Journal of Sports Medicine that the prevention of apparently inexplicable heart attacks amongst numerous young sportsmen and women is seriously challenged due to large gaps in basic knowledge about their causes. Following the recent incident of premier league football player Fabrice Muamba's collapsing on the pitch in front of a packed stadium after sustaining a sudden heart attack, Dr. Weiler and his team call to at least establish a reliable database that includes all these events across all sports in order to...
Date: May-15-2012
New research from Denmark, presented at the 31st Conference of the European Society for Radiotherapy and Oncology (ESTRO31), revealed that even though the human papilloma virus (HPV) can trigger throat cancer, non-smoking or light smoking HPV-positive patients respond well to radiotherapy treatment alone without requiring harmful chemotherapy in addition. Dr Pernille Lassen, a resident in medical and radiation oncology and researcher at the University Hospital in Aarhus, Denmark said that the study findings demonstrated that in comparison with HPV-negative patients, those who were HPV-positive...
Date: May-15-2012
Anyone who has young children is aware of the problems that ingesting small items can cause to a toddler. It's been the bane of toy manufacturers since toy making began. But with two small children of my own in the house, the issue of batteries, especially the small flat silver ones, that must look particularly appealing to a youngster, is not one I'd ever given too much consideration. Many parents have probably overlooked this potential hazard. A child can so easily pick up a small electronic device, that exist in the home in increasing numbers, prize open the battery compartment, that are...